Posts tagged drug products

• Triaminic Cough-Suppressing Vapor Patches Recalled After Child Suffers Seizure

  Staff Writer | June 19, 2006 4:05 PM | 0 CommentsDenver, CO Category: FDA & Prescription Drugs
  

  Novartis AG has recalled its Triaminic cough-suppressing vapor patches and warns consumers to stop using them immediately. The warning applies to both the mentholated cherry and menthol scented versions. A child suffered a seizure after chewing on one of the patches. Novartis said the patches are to be placed on the chest or throat of children as young as 2 to allow vapors to reach the nose...

• Renu MoistureLoc and Fusarium Keratitis

  Staff Writer | June 19, 2006 11:00 AM | 0 CommentsDenver, CO Category: FDA & Prescription Drugs
  

  In early 2006, a cluster of four cases of fusarium keratitis was seen at the University of California, San Francisco. Each of the four patients used ReNu with MoistureLoc. In fact, three of the four had been young, otherwise healthy women who used ReNu with MoistureLoc exclusively. Ironically, it was a cluster of four cases of fusarium keratitis in ReNu with MoistureLoc users in February 2006...

• Lawsuit Claims Sunscreens Don't Protect as Claimed

  Staff Writer | June 19, 2006 9:22 AM | 0 CommentsDenver, CO Category: FDA & Prescription Drugs
  

  In a recent article on CNN.com, attorneys have filed a lawsuit in California Superior Court, alleging that the claims made by labels on sunscreen products are misleading, and not offering all the protection they claim. The lawsuit focuses on some of the products sold by Coppertone, Hawaiian Tropic, Banana Boat, Bull Frog, and Neutrogena, because those products make claims such as "UVB/UVA...

• Bextra/Celebrex Multi District Litigation

  Staff Writer | June 15, 2006 9:31 AM | 0 CommentsDenver, CO Category: FDA & Prescription Drugs
  

  In the Bextra/Celebrex MDL, Judge Breyer is holding a hearing today in San Francisco on Pfizer's motion to dismiss the claims of consumers, labor unions and insurance companies that allege they wrongfully paid for these drugs as a result of Pfizer's improper conduct. A ruling, however, will not be expected for several weeks.

• Johnson and Johnson Will Retest Heart Medication Natrecor

  Staff Writer | June 14, 2006 8:10 PM | 0 CommentsDenver, CO Category: FDA & Prescription Drugs
  

  Johnson and Johnson announced that its Scios unit will spend over $100 million to test the safety and effectiveness of its heart failure drug, Natrecor. The new study will involve 7,000 people and will test safety issues that arose last year when other studies showed that the drug could lead to an increased risk of kidney problems and a higher risk of mortality within the first month of...

• Asthma Drugs Found to Increase Risk of Hospitalization and Death . . . From Asthma!

  Staff Writer | June 14, 2006 8:07 PM | 0 CommentsDenver, CO Category: FDA & Prescription Drugs
  

  The Washington Post recently reported that a new analysis of 19 studies of long-acting asthma medicines, such as Advair and Servent, shows that the risk of hospitalization and death is substantially increased over those who used placebos. "What we have here is a drug that increases the number of people who will die from the disease it is treating," said lead author Shelley Salpeter of Stanford...

• FDA Urges Halt of Ketek Antibiotic Trials in Children

  Staff Writer | June 14, 2006 8:04 PM | 0 CommentsDenver, CO Category: FDA & Prescription Drugs
  

  An official within the FDA called for a halt of clinical trials in children of Sanofi-Aventis' antibiotic, Ketek, based on concerns that the drug might be deadly. The drug is being tested on ear infections and tonsillitis in nearly 4,000 infants and children in over a dozen countries, including the U.S., in spite of its having caused liver failure, blurred vision, and loss of consciousness in...

• Zyprexa Litigation

  Staff Writer | June 14, 2006 8:00 PM | 1 CommentDenver, CO Category: FDA & Prescription Drugs
  

  On June 8th, Judge Weinstein (the federal judge overseeing the Zyprexa litigation and $700 million settlement) issued an order that if claimants in the settlement do not have their claims submitted to the Special Masters with the necessary documents to support their claim "conforming to the guidelines agreed upon in the Final Settlement Protocol" by July 17th, their claims will be deemed...

• Dying Patients have Right to Experimental Drugs

  Staff Writer | June 05, 2006 1:28 PM | 0 CommentsDenver, CO Category: FDA & Prescription Drugs
  

  A federal appeals court has ruled that, just as terminally ill patients have a right to die and refuse treatment, they also have a right to take all measures available to them to sustain their lives. The court's ruling allows dying patients access to experimental drugs that have passed the first phase of FDA review, which determines whether a product is safe, even prior to full FDA approval.The...

• Pfizer Accused of Unapproved Testing on Children

  Staff Writer | June 04, 2006 1:41 PM | 0 CommentsDenver, CO Category: FDA & Prescription Drugs
  

  A panel of Nigerian medical experts issued a report concluding that Pfizer, Inc., illegally tested its unapproved drug, Trovan, on children and infants during a 1996 epidemic of deadly meningitis in Kano, Negeria. Pfizer contends that its use of the unapproved drug was purely for philanthropic reasons, but the Nigerian panel called it a "clear case of exploitation of the ignorant," in its...